Accredited learning modules
RACGP & ACRRM-accredited activities
40 POINTS
This activity focuses on the complex needs of patients presenting with chronic non-cancer pain (CNCP). Start Learning
40 POINTS
This activity focuses on defining neuroendocrine tumour (NET) as a cancer, as well as on the signs, symptoms and classifications of NETs. Start Learning
40 POINTS
Metabolic syndrome diagnosis and management of associated risk factors.
RACGP & ACRRM-accredited activities
3 POINTS
Compare your clinical approach to your peers in an interactive e-learning module with expert commentary and practical tips by Sleep and Respiratory Specialist, A/Professor Jeremy Goldin. Start Learning
2 POINTS
This activity describes benign prostatic hyperplasia (BPH), its common symptoms, diagnosis, and reviews management options in patients who are not effectively managed on oral therapies. The emerging role of minimally invasive surgical options for the treatment of BPH is highlighted. Start Learning
2 POINTS
This education focuses on the identification of patients with treatment-resistant mental health conditions suitable (and eligible) for treatment with cannabidiol (CBD) and CBD-dominant pharmaceutical cannabis. Start Learning
2 POINTS
A case study-based on-demand webinar which looks at providing a patient-centric, tailored approach to the optimal management of chronic obstructive pulmonary disease in general practice. Start Learning
2 POINTS
Best practise management of patients with pancreatic exocrine insufficiency (PEI). Start Learning
2 POINTS
In this activity, Dr Barton Jennings, MBBS, FRACP, Specialist in Respiratory Medicine and Sleep Disorders, discusses the importance of spirometry testing in general practice and demonstrates how to interpret spirometry results using real patient case studies. Start Learning
2 POINTS
This on-demand webinar is based on panel discussion with three eminent healthcare professionals. Start Learning
2 POINTS
An overview of the development and approval processes of biosimilar medicines in Australia, with practical tips on prescribing and counselling. Start Learning
RACP Category 1
In this activity, two of Australia's leading neurologists – A/Prof Piero Perucca and A/Prof Doug Crompton – meet to discuss the identification and mitigation of sudden unexpected death in epilepsy (SUDEP) risk in patients with ongoing/uncontrolled seizures, particularly those experiencing tonic-clonic seizures. Start Learning
This activity will focus on the role of interleukin-17 (IL-17) inhibitors in the treatment of psoriatic arthritis (PsA) patients who showed an inadequate response to conventional disease-modifying antirheumatic drugs (csDMARDs), review the updated treatment guidelines regarding initiation of IL-17 inhibitors, and discuss the clinical evidence to support IL-17 inhibitors. Start Learning
Hear from three of Australia’s top rheumatologists – A/Prof Östör, Dr Tellus and A/Prof Bird – in this videocast-style learning activity. Start Learning
This activity will focus on the management of existing patients diagnosed with RA who are showing incomplete response to conventional disease-modifying antirheumatic drugs (cDMARD) Start Learning
A case study-based activity focusing on patient selection for, and practical aspects of, tyrosine kinase inhibitors in RAI-R DTC. Start Learning
An overview of the development and approval processes of biosimilar medicines in Australia, with practical tips on prescribing and counselling. Start Learning
This on-demand webinar is based on panel discussion with three eminent healthcare professionals. Start Learning
Nurses
This activity focuses on defining neuroendocrine tumour (NET) as a cancer, as well as on the signs, symptoms and classifications of NETs. Start Learning
In this activity, Dr Barton Jennings, MBBS, FRACP, Specialist in Respiratory Medicine and Sleep Disorders, discusses the importance of spirometry testing in general practice and demonstrates how to interpret spirometry results using real patient case studies. Start Learning
An overview of the development and approval processes of biosimilar medicines in Australia. Start Learning
Dietitians
This module covers the pathophysiology of PEI, risk factors, signs and symptoms, complications, diagnosis, management strategies, such as treatment with pancreatic enzyme replacement therapy (PERT), including CREON®. Start Learning
PSA CPD Credits
1 CREDITS
An overview of the development and approval processes of biosimilar medicines in Australia, with practical tips on dispensing and counselling. Start Learning
1 CREDITS
This on-demand webinar is based on panel discussion with eminent healthcare professionals. Start Learning
Coming soon
Past events
Your patients, your government
MULTIDISCIPLINARY FORUM AND WORKSHOP, PARLIAMENT HOUSE, SYDNEY. CLOSED EVENT
Panellists
Clinical Audits
Closed Courses
Ready to take your learning experience to the next level?
GET STARTED
